Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT.
作者信息
Sharma S K, Bagshawe K D, Melton R G, Begent R H
机构信息
CRC Clinical Research Laboratories, Royal Free Hospital School of Medicine, Department of Clinical Oncology, London, UK.
出版信息
Transplant Proc. 1996 Dec;28(6):3154-5.
PMID:8962222
Abstract
摘要
相似文献
1
Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT.
Transplant Proc. 1996 Dec;28(6):3154-5.
2
Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.环孢素可延缓抗体酶偶联物在抗体导向酶解前药疗法中的宿主免疫反应。
Transplant Proc. 1996 Dec;28(6):3156-8.
3
Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs.使用芥子气前药的抗体导向酶前药疗法（ADEPT）。
Anticancer Drug Des. 1995 Jul;10(5):361-72.
4
Development of triazene prodrugs for ADEPT strategy: new insights into drug delivery system based on carboxypeptidase G2 activation.三氮烯前药的研制用于 ADEPT 策略：基于羧肽酶 G2 激活的药物传递系统的新见解。
Bioorg Med Chem Lett. 2012 Nov 15;22(22):6903-8. doi: 10.1016/j.bmcl.2012.09.029. Epub 2012 Sep 18.
5
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.一种抗血管生成剂增强结直肠癌异种移植瘤中抗体导向酶前药疗法的作用
Cancer Res. 1999 Aug 15;59(16):3998-4003.
6
Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2.A5B7单克隆抗体与羧肽酶G2小规模偶联的优化
J Immunol Methods. 1993 Jan 14;158(1):49-56. doi: 10.1016/0022-1759(93)90257-8.
7
Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial.抗体导向酶解前药疗法（ADEPT）临床试验中人类对单克隆抗体-酶偶联物的免疫反应。
Cell Biophys. 1992 Aug-Dec;21(1-3):109-20. doi: 10.1007/BF02789482.
8
Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.用于抗体导向酶前药疗法的新型吡咯并[2,1-c][1,4]苯并二氮杂卓前药的合成与生物学评价
Bioorg Med Chem Lett. 2006 Jan 15;16(2):252-6. doi: 10.1016/j.bmcl.2005.10.017. Epub 2005 Nov 15.
9
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.减毒沙门氏菌将前药激活酶羧肽酶G2靶向小鼠黑色素瘤以及人乳腺癌和结肠癌，以进行有效的自杀基因治疗。
Clin Cancer Res. 2008 Jul 1;14(13):4259-66. doi: 10.1158/1078-0432.CCR-07-4800.
10
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT).修饰治疗性蛋白质上的免疫原性表位：迈向改进的抗体导向酶前药疗法（ADEPT）系统的一步。
Br J Cancer. 2004 Jun 14;90(12):2402-10. doi: 10.1038/sj.bjc.6601888.
引用本文的文献
1
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT).修饰治疗性蛋白质上的免疫原性表位：迈向改进的抗体导向酶前药疗法（ADEPT）系统的一步。
Br J Cancer. 2004 Jun 14;90(12):2402-10. doi: 10.1038/sj.bjc.6601888.
Zotero 插件